Background: Carcinoma of prostate is one of common tumors of old age in men. With digital rectal examination (DRE) prostate-specific antigen (PSA) is a major screening tool for prostate cancer. While Trans Rectal Ultra Sound (TRUS)guided needle biopsies of prostate are considered gold standard for the diagnosis of prostate cancers. Objectives: To determine the spectrum of pathological lesions in TRUS-guided needle biopsies of prostate in men with increased serum PSA levels (≥ 4 ng/ml) with or without symptoms of prostatism.
Background: FNAC is very simple, quick, cost effective and minimally invasive technique used to diagnose different type of swelling occur in lymph node, thyroid gland, soft tissue and salivary gland in head and neck region. Aim and Objective: To evaluate role and utility of FNAC in diagnosis of palpable head and neck lesions Methods: Our study has included 260 patients presented with palpable swelling in head and neck region at our hospital from January 2017 to January 2019. FNAC procedure has been and smears are stained with H & E stain and pap stain. Cyto histopathological correlation were done wherever possible. Results: Out of 260 cases, Lymph node (57.69%) is most common site of aspiration where TB lymphadenitis (53.33%) was most common diagnosed lesion. Thyroid gland lesions constitute 64 cases (24.61%) followed by salivary gland lesions 26 cases (10%), soft tissue lesions 16 cases (6.15%). FNAC was inconclusive in 7 cases (2.69%). Conclusion: FNAC serves as a guide to appropriate therapeutic management whether to locally excise a benign tumor or plan radical surgery and helps as an adjunct to histopathology.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.